AbbVie Inc

ABBV

Company Profile

  • Business description

    AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

  • Contact

    1 North Waukegan Road
    North ChicagoIL60064-6400
    USA

    T: +1 847 932-7900

    E: [email protected]

    http://www.abbvieinvestor.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    50,000

AbbVie Inc News & Analysis

markets

4 charts on the US rotation out of growth and tech stocks

Value stocks among financials, healthcare and consumer defensive sectors are supporting the market.
markets

Markets brief: US value stocks have suffered in 2023 but are showing signs of recovery

These stocks have led the latest gains for the value side of the market.
funds

Under the hood of Australia’s largest sustainable ETF

Despite strong performance and strict exclusion criteria, BetaShares' ETHI includes firms accused of tax evasion.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,552.6071.000.84%
CAC 407,338.6786.93-1.17%
DAX 4019,215.48147.04-0.76%
Dow JONES (US)43,988.99259.650.59%
FTSE 1008,072.3968.35-0.84%
HKSE20,728.19225.15-1.07%
NASDAQ19,286.7817.320.09%
Nikkei 22539,500.37118.960.30%
NZX 50 Index12,770.33188.951.50%
S&P 5005,995.5422.440.38%
S&P/ASX 2008,295.1068.800.84%
SSE Composite Index3,452.3018.36-0.53%

Market Movers